TONIX PHARMACEUTICALS
Live / Registered — Registered and renewed (as of 01 May 2024)
What this means for you
Registered since 16 Dec 2014. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 16 Dec 2024).
Record
- Serial number
- 85088881
- Registration number
- 4656463
- Mark type
- Stylized text
- Filed
- 20 Jul 2010
- Published for opposition
- 02 Aug 2011
- Registered
- 16 Dec 2014
- Next maintenance due
- 16 Dec 2024
- Attorney of record
- Francis J. Duffin
Goods and services
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical research and development
Owner
- TONIX PHARMACEUTICALS, INC., Chatham, NJ, US
- TONIX PHARMACEUTICALS, INC., NEW YORK, NY, US
- Krele Pharmaceuticals, Inc., New York, NY, US
- Krele Pharmaceuticals, Inc., New York, NY, US
Prosecution history
- 01 May 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 01 May 2024 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 01 May 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 01 May 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 09 Jan 2024 — TEAS SECTION 8 & 9 RECEIVED
- 16 Dec 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 13 Feb 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 13 Feb 2020 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 13 Feb 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Dec 2019 — TEAS SECTION 8 & 15 RECEIVED
- 16 Dec 2019 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 16 Dec 2014 — REGISTERED-PRINCIPAL REGISTER
- 08 Nov 2014 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 Nov 2014 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Oct 2014 — STATEMENT OF USE PROCESSING COMPLETE